Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00438087
Other study ID # P051072
Secondary ID
Status Completed
Phase Phase 3
First received February 9, 2007
Last updated July 6, 2012
Start date March 2007
Est. completion date January 2011

Study information

Verified date July 2012
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

Facial palsy after surgical removal of cranial base tumors adherent to the nerve can partly be explained by inflammation.


Description:

Facial palsy after surgical removal of cranial base tumors adherent to the nerve can partly be explained by inflammation.

The purpose of this study was to assess the efficiency of corticosteroids to prevent facial palsy after such surgery and to identify the patients that will have the highest benefit from an anti-inflammatory treatment.

This study will include patients undergoing surgery for a benign tumor of the cranial base (vestibular schwannoma). The efficiency of high dosage corticosteroids administered intravenously during and after surgery will be evaluated on the facial nerve function in comparison to a placebo. Pre operative and intra operative data will be collected and analysed in order to investigate possible predictive factors of response to the treatment.

Introduction: After the surgical removal of a cerebella-pontine angle tumor (mainly vestibular schwannoma), and despite the anatomical integrity of the facial nerve, an immediate or delayed facial palsy may occur. This palsy may be explained by ischemia, edema, inflammation, or a neurotmesis (ruptured axons in an intact nerve sheet). This phenomenon is highly dependent on the size of the tumor. In our preliminary studies, we observed an immediate facial palsy in 16% and a palsy occurring at postoperative day 8 in 23% of the patients operated on for a vestibular schwannoma. Corticosteroids may decrease the inflammation and the edema around the nerve and reduce the incidence of the postoperative facial palsy. Their efficiency has already been demonstrated in idiopathic facial palsy. In a previously published study , a single dose of dexamethasone during surgery did not influence the facial function outcome. But the short period of the treatment do not allow definitive conclusions.

Objectives: The aim of this study is to analyze the effect of a corticosteroid (methyl prednisolone) administered intra- and postoperatively on the incidence of facial palsy after surgery of cerebella-pontine angle tumors and to determine intra operative prognostic factors for the facial function outcome.

Material and Methods: A multi center, prospective, randomized, versus placebo, and double-blind study will be undertaken. Four-hundred patients undergoing surgery for a cerebellopontine angle tumor will be included during 23 months. Three university departments of otolaryngology (Hospital BEAUJON, CHU de Bordeaux, CHU de Tours) will participate. The pre operative assessment includes a clinical examination with the assessment of the facial function (in 6 grades according to House and BRACKMANN), an audiometry and a vestibular testing, and a cranial MRI with the classification of tumors in 4 stages according to their size. Patients will be randomized after information and with their consent. During surgery, the degree of nerve stretch (4 stages), the tumor adhesion to the nerve (4 stages) and the stimulation thresholds of the facial nerve with an electromyographic monitoring device (NIM Response 2, XOMED MEDTRONICS, Jacksonville, FL) will be recorded. All cases of facial nerve interruption during surgery will be excluded. In the treated group, one IV injection of methyl prednisolone at 1 mg/kg/day will be administered intra operatively and on postoperative days 1 and 2. The treatment will be continued on days 3 to 7 with the same dosage orally. Subsequently, 0.5 mg/kg/day at days 8 and 8, and 0.25 mg/kg/day at days 10 and 11. The facial function will be assessed on postoperative days 1, 8 and 30 clinically.

Expected results: Considering the effect of corticosteroids in the idiopathic facial palsy and the effect of these agents on edema and inflammation, we expect and decrease in the incidence of immediate and delayed postoperative facial palsies. The intra operative stimulation thresholds may indicate a subgroup of patients for which the efficiency of the corticosteroids is higher than in the whole series.

Conclusion : The facial palsy after surgery of cerebellopontine angle tumors is the most frequent and the most significant morbidity. Corticosteroids may decrease the incidence of this complication.


Recruitment information / eligibility

Status Completed
Enrollment 313
Est. completion date January 2011
Est. primary completion date March 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adults patients

- surgery of base crane tumors

- accept to participate

- having health insurance

Exclusion Criteria:

- pregnant woman

- children

- known allergy to steroids

- preoperative facial palsy of grade >2

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
methylprednisolone
methylprednisolone administrated intra and post operatively

Locations

Country Name City State
France Assistance Publique Hopitaux de Paris Clichy

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of the facial function at 8 days postoperative at 8 days postoperative Yes
Secondary Assessment of the facial function at 1 day postoperative at 1 day postoperative Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05581680 - Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects N/A
Completed NCT06334796 - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology Early Phase 1
Completed NCT04993417 - Comparison of Motor Imagery Technique and Mime Therapy on Facial Expressions in Facial Palsy Patients N/A
Completed NCT02486393 - Complications in Parotid Surgery N/A
Completed NCT05094245 - Stellate Gnaglion Block in Refractory Bell's Palsy N/A
Recruiting NCT04886245 - Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology. N/A
Recruiting NCT03781700 - Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy Phase 4
Completed NCT03006783 - Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis N/A
Recruiting NCT05981651 - Development and Application of a Dynamic Three-dimensional Quantitative Facial Measurement Device
Recruiting NCT04074018 - Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis N/A
Recruiting NCT04237961 - Ancillary Procedures in Patients of Refractory Facial Palsy Patients Selection and Evaluation of the Outcomes N/A
Recruiting NCT05191719 - Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy N/A
Recruiting NCT03059420 - Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Completed NCT03943953 - Self-guided Psychosocial Intervention for Facial Palsy N/A
Completed NCT03619720 - Emotional Perception and Production in Facial Palsy: Respiratory, Vocal and Facial Markers. N/A
Completed NCT02328079 - Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy N/A